Key Takeaways Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

According to the latest data from the Centers for Disease Control, the current bird flu outbreak has caused 67 human cases of ...

The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

Moderna (MRNA) announced ongoing support from the U.S. Department of Health and Human Services, HHS, to accelerate the development of ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

Agency is now calling for all patients hospitalized with flu to be tested for H5 ... A number of drug companies are working to develop a vaccine, led by Moderna Inc., which won a $176 million ...

have called on the outgoing administration to make bird flu vaccines available to farmworkers exposed to animals infected with the H5N1 avian flu. The administration has consistently said no ...

The Centers for Disease Control and Prevention (CDC) said the "U.S. government is developing vaccines against avian influenza A(H5N1) viruses in case they are needed." According to the CDC ...

(Spencer Platt/Getty Images) An infectious disease expert says the relatively mild cases of avian influenza detected so far among dairy workers don’t warrant making a vaccine available to them ...